Blog – Potsdam Science Park

17.2.22

3 questions to biocyc – “With our new antibody production process, we are one of the few companies in the world that are able to do this”

In a way, biocyc is one of the hidden champions of the Potsdam Science Park. Producing peptides for both the pharmaceutical industry and research as well as antibodies for cancer diagnostics, their success allows them to build their own production building in the Potsdam Science Park. In our interview, biocyc CEO Alexander Gorczyza talks about…

3.2.22

3 questions to Porous – „Quantitative ultrasound technology allows the early detection of osteoporosis.”

Osteoporosis effects billions of people worldwide and creates economic costs of about 60 billion US Dollars annually. Until recently, the early diagnosis of the disorder with conventional means has been nearly impossible. The MedTech startup Porous GmbH, a spin-off of Charité Berlin, is planning to change that. In our interview, CEO Bart Hendriks tells us…

1.2.22

The virtue of small things

At the Max Planck Institute of Colloids and Interfaces in the Potsdam Science Park, Dr. Aleksandr Savateev conducts research in Innovative Heterogeneous Photocatalysis. The field is inspired by the natural photosynthesis of plants – and may help us to conserve many scarce natural resources. Dr. Aleksandr Savateev appreciates small things. Microscopic things, even. Big, flashy…

25.1.22

Dreaming of micro-plastics-free vegetables

For many decades, micro-plastics remained a scarcely researched issue. But awareness is growing, as is the realization that we, too, ingest plastic particles through food and water. Hardly anyone can estimate the consequences. PD Dr. Harald Seitz from Fraunhofer IZI-BB and Dr. Susanne Baldermann from the IGZ dare to take a closer look. They research…

18.1.22

Revolution from the Lab – Coatings from potato-, corn- and pea starch

Coatings protect materials from negative environmental influences. They prevent metals from rusting and wood from swelling. However, over 90 percent of coatings today are still based on synthetic petroleum products. That has negative consequences for the environment. Therefore, Dr. Christina Gabriel-Liebs has long been researching the possibilities of producing coatings from a sustainable raw material:…

13.1.22

3 Questions to QMEDIS – “We are working on the 2D printing of drugs”

Starting in January 2022, new companies and research groups will move into the newly built H-LAB in the Potsdam Science Park. Among them will be QMEDIS Analytics, a contract lab where drugs are not only analysed but also produced. In our interview, Dr. Dennis Stracke explains how the lab works and how drug printers could…